This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
Blood derivative in-vitro diagnostic substances manufacturing
Blood glucose test kits manufacturing
Coagulation in-vitro diagnostic substances manufacturing
Cytology and histology in-vitro diagnostic substances manufacturing
Diagnostic substances, in-vitro, manufacturing
Enzyme and isoenzyme in-vitro diagnostic substances manufacturing
Hematology in-vitro diagnostic substances manufacturing
HIV test kits manufacturing
Hormone in-vitro diagnostic substances manufacturing
In-vitro diagnostic substances manufacturing
Microbiology, virology, and serology in-vitro diagnostic substances manufacturing
Pregnancy test kits manufacturing
Viral in-vitro diagnostic test substances manufacturing
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Answeres comes easily with Industrius CFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine “what if scenarios and P&L impact of reducing costs or adding revenue.
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.